Bisaro Paul
SEC CIK 1237253 · EDGAR
BoughtSold
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 16:24 | 2026-06-04 | MYGN | MYRIAD GENETICS INC | Bisaro Paul | Dir | A - Grant | $0.00 | +59.7K | 157.1K | +61% | $0 | |
| 2026-05-14 17:16 | 2026-05-14 | MYGN | MYRIAD GENETICS INC | Bisaro Paul | Dir | P - Purchase | $3.69 | +7,500 | 97.4K | +8% | +$27.6K | |
| 2026-05-13 16:35 | 2026-05-13 | ZTS | Zoetis | Bisaro Paul | Dir | P - Purchase | $75.88 | +2,000 | 27.9K | +8% | +$151.8K | |
| D | 2026-02-23 | 2026-02-19 | ZTS | Zoetis | Bisaro Paul | Dir | M - OptEx | — | +1,619 | 25.9K | +7% | — |
| 2025-06-06 | 2025-06-05 | MYGN | MYRIAD GENETICS INC | Bisaro Paul | Dir | A - Grant | $0.00 | +49.8K | 89.9K | +124% | $0 | |
| D | 2025-02-11 | 2025-02-08 | ZTS | Zoetis | BISARO PAUL | Dir | M - OptEx | — | +1,225 | 24.2K | +5% | — |
| D | 2025-02-10 | 2025-02-06 | ZTS | Zoetis | BISARO PAUL | Dir | M - OptEx | — | +1,236 | 23.0K | +6% | — |
| 2024-06-07 | 2024-06-06 | MYGN | MYRIAD GENETICS INC | BISARO PAUL | Dir | A - Grant | $0.00 | +15.7K | 40.1K | +64% | $0 | |
| D | 2024-02-13 | 2024-02-10 | ZTS | Zoetis | BISARO PAUL | Dir | M - OptEx | — | +1,463 | 21.8K | +7% | — |
| D | 2024-02-12 | 2024-02-08 | ZTS | Zoetis | BISARO PAUL | Dir | M - OptEx | — | +1,493 | 20.3K | +8% | — |
| 2023-06-02 | 2023-06-01 | MYGN | MYRIAD GENETICS INC | BISARO PAUL | Dir | A - Grant | $0.00 | +7,575 | 24.4K | +45% | $0 | |
| D | 2023-02-14 | 2023-02-11 | ZTS | Zoetis | BISARO PAUL | Dir | M - OptEx | — | +1,626 | 18.8K | +9% | — |
| 2022-11-01 | 2022-10-31 | MYGN | MYRIAD GENETICS INC | BISARO PAUL | Dir | A - Grant | $0.00 | +16.9K | 16.9K | New | $0 | |
| D | 2022-08-22 | 2022-08-18 | TXMD | TherapeuticsMD, Inc. | BISARO PAUL | Dir | M - OptEx | — | +1,984 | 5,922 | +50% | — |
| D | 2022-02-15 | 2022-02-12 | ZTS | Zoetis | BISARO PAUL | Dir | M - OptEx | — | +2,673 | 17.2K | +18% | — |
| 2021-08-18 | 2021-08-16 | TXMD | TherapeuticsMD, Inc. | BISARO PAUL | Dir | P - Purchase | $0.79 | +50.0K | 196.9K | +34% | +$39.5K | |
| D | 2021-08-12 | 2021-08-10 | TXMD | TherapeuticsMD, Inc. | BISARO PAUL | Dir | M - OptEx | — | +96.9K | 146.9K | +194% | — |
Purchase Sale Sale after option exercise All abbreviations